Table:
begin	end	state
1	20	non-cytoplasmic
21	43	transmembrane
44	49	cytoplasmic
50	82	transmembrane
83	92	non-cytoplasmic
93	113	transmembrane
114	122	cytoplasmic
123	140	transmembrane
141	167	non-cytoplasmic
168	188	transmembrane
189	199	cytoplasmic
200	228	transmembrane
229	247	non-cytoplasmic
248	269	transmembrane
270	288	cytoplasmic
289	307	transmembrane
308	324	non-cytoplasmic
325	359	transmembrane
360	377	cytoplasmic
378	406	transmembrane
407	407	cytoplasmic
408	552	non-cytoplasmic

Input:
>AO353_10315
MIAIREAWKAGLLRPEHWLRNIVSGVIVGVVALPLAMAFAIASGVKPEQGIYTAIVSGLL
VSLFGGSRLQIAGPTGAFVVILSGVTAKYGVDGLQIATMMAGAILLLLGITKLGAIIKFI
PDPVIVGFTAGIGVIIWVGQWKDFFGLPKISGEHFHERLWHLVQALPSFHVPTTLLALSS
LVLVITAPKIPGIRRVPGPLIAMVVVTALQAFFQFAGVATIGSAFGGIPQGLPEVGLPAI
TLPQVIELIGPAFAIAMLGAIESLLSAVVADGMAGTKHDSNQELIGQGIANLVTPLFGGF
AATGAIARTATNIRNGGNSPIAGFVHALTLILLILFLAPLASDIPLCALAAILFVVAYNM
SELKHFQRMVKRAPKADVAILLITFSLTVFSDLAIAVNIGVILAMLQFMRRMASSVEVQQ
MVEKELEVELRINGHVRLPPGVLVYTIEGPLFFGAAETFERVLAQTHTDPGTLIIRLKRV
PFMDITGLQTLLEVIEHLRKRSIVVKLCEANEKVLGKLDKAGILQALGPEHYHADFSGAL
GSFEIDKTPHLG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server